GlaxoSmithKline (GSK) Offers Statement in Response to New York Times Article on China
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) said on its website:These matters relating to our operations in China were deeply disappointing to GSK. They ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
